• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素体外抗菌活性与动物感染模型中的抗菌活性的相关性。

Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection.

作者信息

Zak O, Tosch W, Sande M A

出版信息

J Antimicrob Chemother. 1985 Jan;15 Suppl A:273-82. doi: 10.1093/jac/15.suppl_a.273.

DOI:10.1093/jac/15.suppl_a.273
PMID:3980330
Abstract

Laboratory tests of antibiotic activity in vitro, ranging from simple MIC determinations to sophisticated, computerized models for studying the effects of simulated plasma concentration-time curves of antibiotics in broth, differ inherently from tests in vivo in both the general and specific variables. There are therefore likely to be discrepancies between the results obtained. Apart from the obvious lack of host-defence mechanisms in the in-vitro tests systems, the reasons for these discrepancies have still not been fully elucidated. For the time being, it seems unrealistic to expect that in-vitro tests could be developed that would make it possible to predict the efficacy of any antibiotic against any specific infection in vivo.

摘要

抗生素体外活性的实验室检测,从简单的最低抑菌浓度(MIC)测定到用于研究肉汤中抗生素模拟血浆浓度 - 时间曲线影响的复杂计算机模型,在一般变量和特定变量方面都与体内试验存在本质差异。因此,所获得的结果之间可能存在差异。除了体外测试系统明显缺乏宿主防御机制外,这些差异的原因仍未完全阐明。目前,期望开发出能够预测任何抗生素对体内任何特定感染疗效的体外测试似乎是不现实的。

相似文献

1
Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection.抗生素体外抗菌活性与动物感染模型中的抗菌活性的相关性。
J Antimicrob Chemother. 1985 Jan;15 Suppl A:273-82. doi: 10.1093/jac/15.suppl_a.273.
2
Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.抗生素体外活性及药代动力学参数与体内效应的相关性。来自实验性肺炎球菌感染的观察结果。
Dan Med Bull. 1988 Oct;35(5):422-37.
3
Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing.
J Chemother. 1997 May;9 Suppl 1:109-15.
4
Definitions of antibacterial interactions in animal infection models.动物感染模型中抗菌相互作用的定义。
J Antimicrob Chemother. 1993 May;31 Suppl D:167-75. doi: 10.1093/jac/31.suppl_d.167.
5
Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.托利霉素,一种新型抗生素。V. 体外和体内抗菌活性。
J Antibiot (Tokyo). 1972 Jan;25(1):16-24.
6
A new tolypomycin-Y derivative: in vitro and in vivo antimicrobial activity.一种新型抗霉素-Y衍生物:体外和体内抗菌活性
J Antibiot (Tokyo). 1978 Nov;31(11):1195-200. doi: 10.7164/antibiotics.31.1195.
7
The post-antibiotic sub-MIC effect in vitro and in vivo.抗生素后亚抑菌浓度效应的体内外研究
J Antimicrob Chemother. 1993 May;31 Suppl D:159-66. doi: 10.1093/jac/31.suppl_d.159.
8
Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.抗生素体外协同作用和药敏试验结果与实验性小鼠感染结果的相关性。
Crit Rev Microbiol. 1982;10(1):1-76. doi: 10.3109/10408418209113505.
9
Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.头孢泊肟和头孢克肟在体外动力学模型中抗菌活性的药代动力学-药效学建模
Int J Antimicrob Agents. 2005 Feb;25(2):120-9. doi: 10.1016/j.ijantimicag.2004.09.012.
10
Medical relevance of low concentrations of antibiotics.
J Antimicrob Chemother. 1993 May;31 Suppl D:137-48. doi: 10.1093/jac/31.suppl_d.137.

引用本文的文献

1
Genome characterization, pathogenicity, and evaluation of therapeutics of Klebsiella aerogenes in Bombyx larvae infection model.产气克雷伯菌在家蚕幼虫感染模型中的基因组特征、致病性及治疗评估
BMC Microbiol. 2025 Apr 12;25(1):209. doi: 10.1186/s12866-025-03942-4.
2
New solvent options for assays in the larvae model.新型溶剂选择方案,用于幼虫模型中的 检测。
Virulence. 2019 Dec;10(1):776-782. doi: 10.1080/21505594.2019.1659663.
3
Alternative strategies for proof-of-principle studies of antibacterial agents.抗菌剂原理验证研究的替代策略。
Antimicrob Agents Chemother. 2014 Aug;58(8):4257-63. doi: 10.1128/AAC.02473-14. Epub 2014 May 27.
4
Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?抗菌剂对吞噬细胞功能的干扰:免疫调节还是“免疫童话”?
Clin Microbiol Rev. 2000 Oct;13(4):615-50. doi: 10.1128/CMR.13.4.615.
5
Pharmacodynamic activity of a cephalosporin, Ro 40-6890, in human skin blister fluid: antibiotic activity in concert with host defense mechanisms.头孢菌素Ro 40 - 6890在人皮肤疱液中的药效学活性:与宿主防御机制协同的抗生素活性。
Antimicrob Agents Chemother. 1993 Dec;37(12):2622-7. doi: 10.1128/AAC.37.12.2622.
6
Mouse model for evaluation of antibiotic treatment of acute and chronic infections.用于评估急性和慢性感染抗生素治疗的小鼠模型。
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):753-7. doi: 10.1007/BF01975042.
7
Animal models in the evaluation of antimicrobial agents.抗菌药物评价中的动物模型。
Antimicrob Agents Chemother. 1991 Aug;35(8):1527-31. doi: 10.1128/AAC.35.8.1527.
8
Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.通过抗菌药物联合治疗耐甲氧西林金黄色葡萄球菌引起的实验性慢性异物感染取得成功。
Antimicrob Agents Chemother. 1991 Dec;35(12):2611-6. doi: 10.1128/AAC.35.12.2611.
9
Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance.抗菌剂杀菌效果测试:技术性能与临床相关性
Clin Microbiol Rev. 1992 Oct;5(4):420-32. doi: 10.1128/CMR.5.4.420.